350817-16-2

Upstream product

• 99687-40-8 (R,R)-[(E)-2-butenyl]diisopropyl tartrate boronate 

Downstream Products

• 350817-29-7 (2R,3R,4R,5R)-5-{(S)-3-Benzyloxy-2-[(2S,3R)-2-((S)-2-tert-butoxycarbonylamino-3-methyl-butyrylamino)-3-hydroxy-butyrylamino]-propionyloxy}-3-hydroxy-2,4-dimethyl-octadecanoic acid pentafluorophenyl ester 
• 350817-21-9 (2S,3R)-2-{(S)-2-[(2R,3R,4R,5R)-5-((S)-3-Benzyloxy-2-tert-butoxycarbonylamino-propionyloxy)-3-hydroxy-2,4-dimethyl-octadecanoylamino]-3-methyl-butyrylamino}-3-hydroxy-butyric acid benzyl ester 
• 350817-28-6 N-[(1,1-dimethylethoxy)carbonyl]-L-valyl-L-threonyl-O-(phenylmethyl)-L-serine (1R)-1-[(1R,2R,3R)-3-carboxy-2-hydroxy-1-methylbutyl]tetradecyl ester 
• 350817-36-6 (S)-3-Benzyloxy-2-[(2S,3R)-2-((S)-2-tert-butoxycarbonylamino-3-methyl-butyrylamino)-3-hydroxy-butyrylamino]-propionic acid (R)-1-((1R,2R,3R)-2-hydroxy-1,3-dimethyl-4-oxo-butyl)-tetradecyl ester 
• 350817-30-0 (3S,6S,9S,12R,13R,14R,15R)-3-Benzyloxymethyl-13-hydroxy-6-((R)-1-hydroxy-ethyl)-9-isopropyl-12,14-dimethyl-15-tridecyl-1-oxa-4,7,10-triaza-cyclopentadecane-2,5,8,11-tetraone 
• 350817-20-8 (2R,3R,4R,5R)-5-[ ((2S)-3-(benzyloxy)-2-{[(tert-butoxy)carbonyl]amino}propanoyl)oxy]-3-hydroxy-2,4-dimethyloctadecanoic acid 
• 147334-89-2 Stevastelin B 
• 350817-34-4 (S)-3-Benzyloxy-2-tert-butoxycarbonylamino-propionic acid (R)-1-((1R,2R,3R)-2-hydroxy-1,3-dimethyl-4-oxo-butyl)-tetradecyl ester 
• 350817-27-5 (S)-3-Benzyloxy-2-[(2S,3R)-2-((S)-2-tert-butoxycarbonylamino-3-methyl-butyrylamino)-3-hydroxy-butyrylamino]-propionic acid (R)-1-((1R,2S,3S)-2-hydroxy-1,3-dimethyl-pent-4-enyl)-tetradecyl ester 

Relevant academic research and scientific papers

Total synthesis of stevastelin B, a novel immunosuppressant

Total synthesis of stevastelin B is described. Evans asymmetric aldol methodology and Roush asymmetric allylation were used to construct four consecutive stereo-centers on the octadecanoic acid moiety of stevastelin B. Subsequent coupling with a dipeptide